Showing 1 - 7 results of 7 for search 'Kim TE', query time: 0.05s Refine Results
  1. 1
    Dose-proportional pharmacokinetic properties of GLA5PR GLARS-NF1 controlled-release pregabalin in healthy Korean volunteers: a randomized, open, single-dose, parallel study

    Dose-proportional pharmacokinetic properties of GLA5PR GLARS-NF1 controlled-release pregabalin in healthy Korean volunteers: a randomized, open, single-dose, parallel study by Shin KH, Jeon JY, Jang K, Kim TE, Kim MG

    Published 2018
    Connect to this object online.
    Book
    Save to List
    Saved in:
  2. 2
    Comparative steady-state pharmacokinetic study of an extended-release formulation of itopride and its immediate-release reference formulation in healthy volunteers

    Comparative steady-state pharmacokinetic study of an extended-release formulation of itopride and its immediate-release reference formulation in healthy volunteers by Yoon S, Lee H, Kim TE, Lee S, Chee DH, Cho JY, Yu KS, Jang IJ

    Published 2014
    Connect to this object online.
    Book
    Save to List
    Saved in:
  3. 3
    Effect of epigallocatechin-3-gallate, major ingredient of green tea, on the pharmacokinetics of rosuvastatin in healthy volunteers

    Effect of epigallocatechin-3-gallate, major ingredient of green tea, on the pharmacokinetics of rosuvastatin in healthy volunteers by Kim TE, Ha N, Kim Y, Kim H, Lee JW, Jeon JY, Kim MG

    Published 2017
    Connect to this object online.
    Book
    Save to List
    Saved in:
  4. 4
    Lack of the effect of lobeglitazone, a peroxisome proliferator-activated receptor-γ agonist, on the pharmacokinetics and pharmacodynamics of warfarin

    Lack of the effect of lobeglitazone, a peroxisome proliferator-activated receptor-γ agonist, on the pharmacokinetics and pharmacodynamics of warfarin by Jung JA, Lee SY, Kim TE, Kim JR, Kim C, Huh W, Ko JW

    Published 2015
    Connect to this object online.
    Book
    Save to List
    Saved in:
  5. 5
    Effect of green tea catechins on the pharmacokinetics of digoxin in humans

    Effect of green tea catechins on the pharmacokinetics of digoxin in humans by Kim TE, Shin KH, Park JE, Kim MG, Yun YM, Choi DH, Kwon KJ, Lee J

    Published 2018
    Connect to this object online.
    Book
    Save to List
    Saved in:
  6. 6
    Multiple-dose pharmacokinetics and pharmacodynamics of evogliptin (DA-1229), a novel dipeptidyl peptidase IV inhibitor, in healthy volunteers

    Multiple-dose pharmacokinetics and pharmacodynamics of evogliptin (DA-1229), a novel dipeptidyl peptidase IV inhibitor, in healthy volunteers by Gu N, Park MK, Kim TE, Bahng MY, Lim KS, Cho SH, Yoon SH, Cho JY, Jang IJ, Yu KS

    Published 2014
    Connect to this object online.
    Book
    Save to List
    Saved in:
  7. 7
    A proposal for an individualized pharmacogenetic-guided isoniazid dosage regimen for patients with tuberculosis

    A proposal for an individualized pharmacogenetic-guided isoniazid dosage regimen for patients with tuberculosis by Jung JA, Kim TE, Lee H, Jeong BH, Park HY, Jeon K, Kwon OJ, Ko JW, Choi R, Woo HI, Koh WJ, Lee SY

    Published 2015
    Connect to this object online.
    Book
    Save to List
    Saved in:

Search Tools: